Cytogen completes Cellcor purchase

Article

Monoclonal antibody firm Cytogen of Princeton, NJ, has completedits purchase of Cellcor, a biotech therapy developer based inNewton, MA (SCAN 7/19/95). Cellcor has been merged into Cytogenas a wholly owned subsidiary, Cytogen

Monoclonal antibody firm Cytogen of Princeton, NJ, has completedits purchase of Cellcor, a biotech therapy developer based inNewton, MA (SCAN 7/19/95). Cellcor has been merged into Cytogenas a wholly owned subsidiary, Cytogen said.

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.